Evidence map›Paper›PMID 36272050›Full record

ReviewCurrent cardiology reports2022

Donation After Circulatory Death: A New Frontier.

Yashutosh Joshi, Jeanette Villanueva, Ling Gao, Bridget Hwang, Christine Zhao, Aoife Doyle, Jianxin Wu, Paul Jansz, Peter Macdonald

Abstract readReview
In one paragraph

Review in Current cardiology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yashutosh JoshiHeart & Lung Transplantation Unit, St. Vincent's Hospital Sydney, 390 Victoria St, Darlinghurst, NSW, 2010, Australia. yashutosh.joshi@svha.org.au.ORCID 0000-0003-0881-2436
Jeanette VillanuevaVictor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia.
Ling GaoVictor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia.
Bridget HwangVictor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia.
Christine ZhaoVictor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia.
Aoife DoyleVictor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia.
Jianxin WuVictor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia.
Paul JanszHeart & Lung Transplantation Unit, St. Vincent's Hospital Sydney, 390 Victoria St, Darlinghurst, NSW, 2010, Australia.
Peter MacdonaldHeart & Lung Transplantation Unit, St. Vincent's Hospital Sydney, 390 Victoria St, Darlinghurst, NSW, 2010, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewTo highlight the current global experience with DCD heart transplantation and explore the evolution of, and compare preservation strategies; examine early clinical outcomes, and discuss the growing use of DCD donors as a new frontier in heart transplantation. RECENT

findingsThe two strategies of DCD heart preservation include NMP using the OCS Heart and TA-NRP followed by either: NMP or CSS. Better understanding the limits of cold ischaemia following TA-NRP will aid in distant procurement. Asystolic warm ischaemia plays an important role in determining immediate post-operative graft function and potential need for mechanical support. Large volume DCD heart transplant units show no difference in survival between DCD and DBD donor heart transplants. In a previously non-utilised source of donor hearts, often viewed as an "unknown frontier" in heart transplantation, DCD hearts are a suitable alternative to brain-dead donor hearts and are likely to remain a permanent part of the heart transplantation landscape. Global uptake is currently increasing, and as understanding of preservation strategies and tolerable ischaemic times improve, utilisation of DCD hearts will continue to grow.

Indexed as

Heart TransplantationHeartHumansPerfusionTissue DonorsDonation after circulatory deathHeart failureHeart transplantationNormothermic machine perfusionNormothermic regional perfusionOrgan preservation

Identifiers

PMID36272050
PMCPMC9747832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.